Viewing Study NCT04758767


Ignite Creation Date: 2025-12-25 @ 12:43 AM
Ignite Modification Date: 2026-02-21 @ 11:18 PM
Study NCT ID: NCT04758767
Status: COMPLETED
Last Update Posted: 2025-04-03
First Post: 2021-02-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: CID-103 (Anti-CD38 Antibody) in Previously Treated Relapsed or Refractory Multiple Myeloma
Sponsor: CASI Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module